Blood Journals Portfolio by ASH with 7 Issues: A Landmark in Hematology Publishing
Blood Journals Portfolio shared an exciting post on LinkedIn:
”We are excited to introduce the Blood Journals Portfolio page. The portfolio consists of Blood and Blood Advances, as well as five specialty journals, publishing high quality research focused on the narrow specialties within hematology: Blood Global Hematology, Blood Immunology and Cellular Therapy, Blood Neoplasia, Blood Red Cells and Iron, and Blood Vessels, Thrombosis and Hemostasis. Through this portfolio page, the American Society of Hematology’s journals keep you informed on the latest hematologic research, celebrate authors who publish in the portfolio, connect you with your peers and experts in the field, and much more. Welcome!”
The American Society of Hematology (ASH) proudly presents its comprehensive Blood Journals Portfolio, featuring Blood and Blood Advances, alongside five specialty journals:
- Blood Global Hematology
- Blood Immunology and Cellular Therapy
- Blood Neoplasia
- Blood Red Cells and Iron
- Blood Vessels, Thrombosis and Hemostasis.
Together, these journals reflect ASH’s commitment to advancing high-quality research across the full spectrum of hematology.
All the latest news in the World of Hematology featured in Hemostasis Today.
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 10, 2025, 23:00Blood Vessels, Thrombosis and Hemostasis - Blood VTH and Blood Neoplasia: Now Indexed in PubMed!
-
Sep 10, 2025, 13:00Shivani Modi Presents 7 Posters at SOHO 2025: From AI to Hematologic Emergencies
-
Sep 10, 2025, 09:27Deep Vein Thrombosis (DVT) Explained in One Slide: Causes, Symptoms, Diagnosis and Treatment
-
Sep 10, 2025, 09:20Giuseppe Biondi Zoccai Celebrates Release of New Book on Medical Statistics
-
Sep 10, 2025, 22:34Nicolas Gendron on The Emerging Role of CLIA in The Diagnosis Strategy for HIT
-
Sep 10, 2025, 21:13Gregory Piazza on The Link Between VTE and Atherothrombosis
-
Sep 10, 2025, 19:00Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
-
Sep 10, 2025, 08:20Flora Peyvandi on Caplacizumab: Which VWF Assays Truly Measure Treatment Effectiveness?
-
Sep 10, 2025, 03:36International Journal of Stroke: Rising Incidence of Stroke in Young Adults
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
-
Sep 9, 2025, 10:34James Douketis Receives the 2025 Distinguished Service Award in General Internal Medicine!
-
Sep 9, 2025, 08:07Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders
-
Sep 9, 2025, 04:57World Thrombosis Day 2025: Louise Bannon Invites Donations and Partnerships